Journal of Clinical Epidemiology
Volume 59, Issue 3 , Pages 315-322 , March 2006

Delayed diagnosis of females with respiratory presentation of cystic fibrosis did not segregate with poorer clinical outcome

,Accepted 13 July 2005.

References 

  1. Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361:681–689
  2. Fogarty A, Hubbard R, Britton J. International comparison of median age at death from cystic fibrosis. Chest. 2000;117:1656–1660
  3. McCormick J, Green MW, Mehta G, Culross F, Mehta A. Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet. 2002;10:583–590
  4. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997;145:794–803
  5. Lai H-C, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol. 2002;156:165–173
  6. Patrone C, Cassel TN, Pettersson K, Piao YS, Cheng G, Ciana P, et al. Regulation of postnatal lung development and homeostasis by estrogen receptor β. Mol Cell Biol. 2003;23:8542–8552
  7. Sherrill DL, Stein R, Halonen M, Holberg CJ, Wright A, Martinez FD. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol. 1999;104:28–36
  8. Baraldo S, Saetta M. Sex differences in airway anatomy over human lifespan. In:  Buist S,  Mapp CE editor. Respiratory diseases in women. European Respiratory Monographs. Vol. 8, No. 25:Sheffield, UK: European Respiratory Society; 2003;p. 1–7
  9. Lai HJ, Cheng Y, Cho H, Kosorok MR, Farrell PM. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol. 2004;159:537–546
  10. Mehta G, Sims EJ, Culross F, McCormick J, Mehta A. Potential benefits of the UK CF Database. J R Soc Med. 2004;97:60–71
  11. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73:1251–1254
  12. Bland M. An introduction to medical statistics. 3rd ed.. Oxford: Oxford University Press; 2000;
  13. Sims EJ, McCormick J, Mehta G, Mehta A. Newborn screening for cystic fibrosis is associated with reduced treatment intensity. J Pediatr. 2005;147:306–311
  14. Schechter MS, Shelton BJ, Margolis PA, FitzSimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163:1331–1337
  15. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, et al. Incidence, population, and survival of cystic fibrosis in the UK, 1968–95. Arch Dis Child. 1997;77:493–496
  16. Frederiksen B, Thorsteinsson SL, Koch C, Hoiby N. Improved prognosis for patients with cystic fibrosis: a result of aggressive center-based treatment. Ugeskr Laeger. 1997;159:5790–5794
  17. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326:1187–1191
  18. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol. 1995;48:1041–1049
  19. Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis. J Hum Nutr Diet. 2001;14:83–91
  20. Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis. Soc Sci Med. 2001;53:1163–1174

PII: S0895-4356(05)00330-6

doi: 10.1016/j.jclinepi.2005.07.016

Journal of Clinical Epidemiology
Volume 59, Issue 3 , Pages 315-322 , March 2006

Article Tools

* Image Usage & Resolution